Browsing Tag
psychedelic biotech
2 posts
After AbbVie took bretisilocin, what’s next for Gilgamesh Pharma’s neuropsychiatric pipeline?
Gilgamesh Pharma, newly spun out from the AbbVie deal, holds a promising psychiatric drug pipeline. Here's what the industry should expect next.
Who’s funding the psychedelic revolution in pharma? Follow the money from PIPEs to Big Pharma M&A
Psychedelic biotech is evolving—from VC hype to pharma buyouts. Discover who’s funding the next generation of depression treatments in 2025.